Evercore ISI Trims IQVIA (NYSE:IQV) Target Price to $250.00 : vimarsana.com

IQVIA (NYSE:IQV – Free Report) had its price objective cut by Evercore ISI from $275.00 to $250.00 in a report issued on Friday morning, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. IQV has been the topic of a number of other reports. UBS Group boosted their target price […]

Related Keywords

Leerink Partnrs , Robertw Baird , Company Profile , Riverview Trust Co , Research Development Solutions , Wealth Management , Contract Sales Medical Solutions , Advisornet Financial Inc , Holdings Inc , Rise Advisors , Technology Analytics Solutions , Securities Exchange Commission , Barclays , Free Report , Truist Financial , Moderate Buy , Get Free Report , Eric Sherbet , Ari Bousbib , Exchange Commission , Net Financial Inc , Activest Wealth Management , Analytics Solutions , Development Solutions , Contract Sales , Iqvia , Nyse Iqv , Iqv , Medical , Lower Price Target , Evercore Isi ,